Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.335 USD | -3.96% |
|
-23.12% | -60.06% |
07-02 | Coherus BioSciences Grants Apotex License to Distribute Toripalimab in Canada | MT |
07-01 | Baird Trims Price Target on Coherus BioSciences to $8 From $9, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.06% | 159M | |
+16.69% | 121B | |
+17.76% | 110B | |
+17.23% | 25.98B | |
-24.22% | 19.27B | |
-18.56% | 15.99B | |
-18.39% | 15.66B | |
-47.75% | 14.5B | |
+57.04% | 14.47B | |
+5.00% | 13.91B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Baird Trims Price Target on Coherus BioSciences to $8 From $9, Maintains Outperform Rating